Support from readers like you keeps The Journal open.
You are visiting us because we have something you value. Independent, unbiased news that tells the truth. Advertising revenue goes some way to support our mission, but this year it has not been enough.
If you've seen value in our reporting, please contribute what you can, so we can continue to produce accurate and meaningful journalism. For everyone who needs it.
Kayla, Sam and Sarah Bailey Fiona Bailey
Fiona Bailey
PARENTS OF CHILDREN with a rare genetic condition have called for negotiations between the HSE and a pharmaceutical company over access to a drug to be sped up.
Last month, the HSE confirmed that it would not reimburse Spinraza (also known as Nusinersen) at its current price.
The organisation said the medication would cost more than €20 million over a five-year period – €600,000 per patient for the first year and €380,000 per patient per year thereafter.
Biogen, the company which makes Spinraza, said these figures are out of date but, when asked by TheJournal.ie to elaborate, said it “cannot comment on pricing”.
Twenty-six children in Ireland who have Spinal Muscular Atrophy (SMA), a rare and life-limiting muscle-wasting condition, could benefit from Spinraza.
Fiona Bailey, whose son Sam has SMA, said it is “heartbreaking” and “frustrating” for parents to watch protracted negotiations while their children become weaker.
Twenty-five of the 28 countries in the European Union have granted access to the medication, except Ireland, the UK (bar Scotland) and Estonia.
SMA Ireland has called on the HSE to reverse its decision; and held a protest outside Leinster House on 28 February.
Negotiations, and clashes, over pricing are ongoing behind the scenes. Biogen has hit out at the process used by the National Centre for Pharmacoeconomics (NCPE) to assess the cost-effectiveness of medication.
In turn, the NCPE’s Director, Professor Michael Barry, sharply criticised the “exorbitant” prices charged by pharmaceutical companies for certain medication, such as Spinraza.
In December 2017, the NCPE did not recommend the reimbursement of Spinraza as it was not deemed “cost-effective”. Its estimated the cost at that time was €37.88 million over five years.
As well as the cost, the HSE also cited the “limitations of the current evidence on clinical effectiveness” of Spinraza when announcing its decision not to reimburse the drug last month.
‘Urgent reform needed’
Biogen has criticised the process used by the NCPE in assessing medication. A spokesperson said: “In SMA there are challenges associated with producing the type of data that the NCPE need to see when reviewing Nusinersen in a general health technology assessment process to determine cost-effectiveness.
“For example, measuring quality of life in a young paediatric population is very difficult, and yet it is a major determining factor of cost-effectiveness in the NCPE process.”
The spokesperson said other challenges “include the uncertainty around long-term health outcomes that inevitably come with a significant therapeutic advancement”.
While the data we have so far is extremely compelling, there are only so many years of data available and limited comparators, which makes determining cost-effectiveness very difficult.
“In more specialised reimbursement methodologies, such as what is now available in Scotland, these kinds of factors are considered.”
Biogen has repeatedly called on the HSE to “urgently reform the appraisal process for orphan medicines like Nusinersen – to allow a greater degree of flexibility for the assessment of such treatment options”.
‘An easy target’
When asked about Biogen’s comments, Professor Barry defended the process used by the NCPE, saying the company’s statement is “typical of what we have come to expect from the pharmaceutical industry here in Ireland”.
He told TheJournal.ie the assessment process is “an easy target for the industry” and “an excuse for not dealing with the fundamental problem of exorbitant pricing of medicines that frequently add little in terms of health outcomes”.
“The failure to reimburse these extremely high-cost drugs is not due to the assessment process, it is due to a funding issue. One of the main purposes of the assessment process is to support the HSE in its discussions and negotiations with the pharmaceutical companies.
I would argue that it is not the assessment process that should be “urgently reformed” but the unrealistic pricing strategies being practiced by the pharmaceutical industry. There is a very clear way to get drugs reimbursed in Ireland and that is to price them fairly.
Barry said we often hear the industry talk about pricing but “rarely about value”.
The reality is that many of the new expensive medicines offer little in terms of health outcomes. In many cases we would be far better off placing our scarce healthcare resources into other areas of the health service like looking after our elderly patients, investing in mental health and disabilities not to mention investing in general practice.
The National Institute for Health and Care Excellence (NICE) in the UK met again last week to discuss reimbursing Spinraza. A decision is expected next month.
Barry added that highlighting what is going on in other countries is “also of limited value”.
“I have not heard anyone discuss the Orkambi situation in England, where reimbursement is still not approved almost two years after the drug was reimbursed in Ireland.
In addition, the concept that drugs should be reimbursed in Ireland just because they are reimbursed elsewhere is a flawed argument as it does not consider value of the drug or the differences in healthcare systems across Europe, the differing abilities to pay and, crucially, the complete absence of transparency of the various ‘deals’ being done in the different countries.
Barry said the problem is “a direct result of pharma pricing strategies”, adding: “The answer is in their own hands.”
Advertisement
Last month Barry told the Sunday Business Post the HSE had already “almost exhausted” the available funding for new drugs for the whole of 2019.
‘The weakest children in Ireland’
About one in 11,000 babies are affected by SMA – a debilitating disease that causes progressive muscle weakness and loss of movement due to muscle wasting.
SMA is the number one genetic cause of death of infants and is in the same family as motor neurone disease.
The most common form of the disease is 5q SMA, which has four different types: 1, 2, 3 and 4– based on age of onset and the highest physical milestone achieved. Type 1 is the most severe form of SMA and accounts for between 50–70% of cases of childhood onset SMA. About 95% of children with Type 1 who are untreated die before the age of two.
SMA Ireland
SMA Ireland
Children who have been granted access to Spinraza, have generally responded well, with some gaining strength and motors skills and reaching milestones previously thought impossible. The medication is delivered through the lower back via a lumbar puncture.
Sam Bailey is one of the 26 children who could benefit from the drug; he has SMA Type 2. His mother Fiona is among the parents who have been campaigning for access to Spinraza. She gave an impassioned speech at the recent rally outside Leinster House.
Speaking to TheJournal.ie, Fiona said waiting for a decision while negotiations go on behind the scenes is “heartbreaking”.
“Twenty-five other countries [in the EU] granted access to Spinraza, some as long as a year ago.
“The details are up to Biogen and the NCPE to hammer out. Our lives are full with trying to contain this disease and keep out children pain-free.”
Fiona Bailey, whose son Sam has SMA, calling for access to 'miracle drug'Spinraza. She says Sam and other children with the rare muscle-wasting condition need access to Spinraza urgently. pic.twitter.com/3cEsYvDvk3
Fiona said she’d “move over [to Scotland] in the morning if Sam could get the drug” but that it isn’t available to people from other countries.
We’re part of the EU, how can we be any different? To me it’s nonsensical, our kids are not getting same treatment as kids in other countries … Our country is failing these children spectacularly.
Parents in Ireland are keeping a close eye on Spinraza negotiations in the UK. Two babies and a teenager have died since the start of the campaign there. “Is that what’s going to happen in Ireland? It’s just terrifying for parents,” Fiona said.
Sam and the other 25 kids are the most vulnerable kids in the country – they can’t do anything for themselves, they need 24-hour care.
She said families “will be back outside the gates of the Dáil” if they need to be but she hopes the situation will be resolved soon.
“It’s terrible to have to put our children through that – children in wheelchairs outside Leinster House, literally begging for their lives.”
‘It’s a miracle he’s still alive’
Sam celebrated his ninth birthday last Wednesday. Fiona said her son is “the same as any other kid” and “was delighted with himself” on the day. However, he is aware of what is going on.
Sam will not see his teenage years if he doesn’t get Spinraza, the fact he’s here today is actually a miracle.
“He was borderline Type 1 at diagnosis, those children don’t normally see their second birthday.
“One chest infection could put Sam in hospital, could put him in ICU. If he gets sick, his life hangs in the balance – he’s one of the most severe sufferers of Type 2 in the country.”
The Bailey family at Sam's ninth birthday party during the week. Fiona Bailey
Fiona Bailey
Fiona said she is obviously aware that Spinraza is an expensive drug but pointed out that so is a spell in ICU or full-time care, which would need to be provided if “God forbid, anything happened me or Paul (Sam’s father)”.
She said getting access to Spinraza would not only be life-changing for Sam but for the whole family. “Sarah and Kayla (his sisters, who are about to turn three and seven) are watching him get weaker, they’re seeking reassurances too,” she said.
“He is losing strength every single month, every single week.”
‘Very vulnerable group’
When asked about the ongoing negotiations, a spokesperson for the HSE said “it would be inappropriate to comment” beyond its recent statement until the process is complete.
In its statement last month the HSE said it “regrets” that it has to date been unable to come to an agreement with Biogen.
Sarah, Sam and Kayla Bailey at Dublin Zoo Fiona Bailey
Fiona Bailey
The HSE said when assessing Spinraza, the organisation’s Drugs Group focused on two areas: reviewing the evidence of the clinical effectiveness of drug (the benefits for patients undergoing clinical trials) and the cost-effectiveness of the drug.
“While the HSE is anxious to provide all possible support to this very vulnerable group of patients and those who care for them, the decision reached by the Leadership Team concurs with the recommendation of the Drugs Group, which is that reimbursement could not be approved at the price currently being charged by the pharmaceutical company,” the statement said.
Under the requirements of the Health (Pricing and Supply of Medical Goods) Act 2013, Biogen has 28 days from the date of notification to respond or make representations to the HSE’s proposed decision.
To embed this post, copy the code below on your site
Close
13 Comments
This is YOUR comments community. Stay civil, stay constructive, stay on topic.
Please familiarise yourself with our comments policy
here
before taking part.
A very poignant and emotional moment felt during the #Shineyourlight. Really brought it all home. RTE should follow up and repeat this image every day at 6 O’clock in place of the Angelus at least for the duration of the emergency. Stay safe all cool heads/clean hands.
@Sean Brennan: or they could use images from tonight during the angelus to keep everyone happy. Poignant is the only word for tonight alright. Stay safe
Seriously, not every item has to become a political issue.
This is just a nice simple gesture of hope and solidarity.
Let’s keep it that way. There are plenty of other threads to voice your discontent.
Well done to my country. You have made me proud during these dark days.
@2thFairy: unfortunately it is being promoted/pushed by politicians. when was the last time you heard of a show of gratitude been advertised on the radio.
@2thFairy: The politicians taking part and promoting themselves doing so have made it a political issue. Aside from that, literally everything is politics!
@alphasully: We don’t usually find ourselves in situations such as this to have a history of advertising them! Has it struck you that perhaps these things are being advertised for those who are cocooning alone, have spoken to no one in days or weeks, don’t have social media and otherwise wouldn’t know about them? That they are advertised in order to try and ensure and maintain some sense of community and connectivity? Not everything has to be political or cynical. If you’ve nothing good to say, just say nothing
@2thFairy: yes I couldn’t agree more, lets all stop criticising politicians and pretend we didn’t vote for FFG in the GE and then announce you will next time as they are doing a marvellous job.. NPHET are making all decisions apart from ports as Leo takes his orders from Brussels. Never forget how these people have behaved.
@Ciaran Goggins: Ah go on outta that for Gods sake. Always one begrudger. Citizens showing SOLIDARITY has nothing to with how they’re paid. Nowt good to say? Say nothing so. Good boy.
For once could ye not just scroll on and keep the moaning and whinging to yourselves. My whole road is lit up as a mark of respect to the dead, the ill and the frontline workers.
It looks beautiful and is a sign that a lot of people are sparing a thought. Just leave it at that and whinge somewhere else for once in your bloody lives.
@Dara O’Brien: Couldn’t agree more. So many people feel lonely and/or at a loss, this gesture of solidarity harms no-one and may very well be of help to many. I can’t understand anyone going to the trouble of commenting negatively on it, but I guess there are always a few sadly
@Brendan O’Donoghue: I can’t believe people think Ireland is doing well. The death rate per million population is no better than the USA. More action is needed. All arrivals on the island must be quarantined for two weeks. Until that happens, how can thing improve?
@Tanks a Minion: sock of this comment. Look at the deaths per million in Andorra and San Marino then have a think for yourself. The US has so far had 1,700 deaths today, increasing their deaths per million by 3. Our 33 increased our by 8. But if you want to go by per million stats then we’ve done 2,000 more tests per million than the US and 5,000 per million more than the US. But that’s not a good indicator for the reasons I’ve already stated.
@meh: he’s correct
It’s not your fault your are too stupid to underhand it
Compare australia and their measures and stats vs us , maybe then you’ll understand the incompetence and miss management
@Dave O’Keeffe: are you for your real ? You are being San Marino into it of course they have distorted numbers look at any OECD country with a population greater than 500k
I’m sorry but these shows of solidarity appear too forced and not spontaneous. if we mean this then these shows of gratitude should be daily, not at the whims of politicians or persons or authority
@alphasully: stoppit. It was a lovely gesture. Neighbours came out to introduce themselves in some cases, offer help if needed. Not forced, you didn’t have to do anything, you could stay on your sofa and watch TV if that’s your desire. It was heart warming and anything that brings us together in these dark days has to be positive. Somebody has to think of it, put it out there and get us together. How else could it be spontaneous?
Here’s a novel idea pay them what they deserve .. give them tax breaks on over time during this crisis.. lighting candles etc . Are all great but show the support from the top not just lip service and gestures as nice as they are ..
@John kavanagh: true but the ordinary person can’t grant that so it’s nice for people to show support in whatever way they can. If front line staff aren’t treated with more respect by the politicians in this country after this then they never will be. Let’s hope they will be, but at the moment it’s lovely to see every day people showing support in whatever way they can.
Thank you also to the trade unions who have ensured HSE workers have decent pay and conditions. Time for hospitialty workers to follow the tireless and heroic example of these great people in joining a union.
I wonder how many of the covidiots lit a light in their holiday homes today in solidarity. I’d bet all of them did but they have no insight into how their selfishness is exacerbating the situation.
@Ale Ceaser: great, we’ll come on everybody, let’s make this a weekly thing. We still have a long road ahead of us, so let’s keep this going, thanking the frontline staff, and honouring all those who have passed and are still fighting this. And it will give us a focus to make it better and more of an impact every week. #ShineYourLight
I understand that people need hopexin a time when they feel scared.
Our healthcare staff shouldn’t have to be heroes. The hollowed out healthcare system forces them into that role. The learning from this is to look after the workers that really are deserving respect like those keeping us healthy fed and the bins emptied. The melodramatic narrative of those who feel they are born to rule is nauseating in the face of the choices made previously to put them at risk.
Disgusting to see so many Shinners hijacking the comments section with their usual whinging and moaning in an effort to steer the Cult Of Sinn Féin into power. SF disappeared once there was a crisis. Cowards. The political figures put in place by the Army Council have shown themselves up to be unsuited to any position of responsibility and decision making.
Whinge. Moan. Whinge. Moan. Never offer a solution. The SF way.
@Mick Early: Too True Mike
All entry ports should have been on lockdown since day one ,only open for essential transport of goods and services. For all the years the government was in power they had no money to pay the pensioners their rightful pension or run the HSE Now they are encouraging and opening the way for Visitors/ Irish to flock into the country without paying much attention to health checks at point of entry.
Harris on US mission to protect jobs as Martin breathes sigh of relief after surviving Trump
2 hrs ago
1.4k
moving day
McIlroy tied for fifth despite Saturday struggles at The Players Championship
The 42
2 hrs ago
710
1
Yemen
Trump announces 'decisive and powerful military action' as strikes start in Yemen
Updated
6 hrs ago
54.8k
Your Cookies. Your Choice.
Cookies help provide our news service while also enabling the advertising needed to fund this work.
We categorise cookies as Necessary, Performance (used to analyse the site performance) and Targeting (used to target advertising which helps us keep this service free).
We and our 157 partners store and access personal data, like browsing data or unique identifiers, on your device. Selecting Accept All enables tracking technologies to support the purposes shown under we and our partners process data to provide. If trackers are disabled, some content and ads you see may not be as relevant to you. You can resurface this menu to change your choices or withdraw consent at any time by clicking the Cookie Preferences link on the bottom of the webpage .Your choices will have effect within our Website. For more details, refer to our Privacy Policy.
We and our vendors process data for the following purposes:
Use precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a device. Personalised advertising and content, advertising and content measurement, audience research and services development.
Cookies Preference Centre
We process your data to deliver content or advertisements and measure the delivery of such content or advertisements to extract insights about our website. We share this information with our partners on the basis of consent. You may exercise your right to consent, based on a specific purpose below or at a partner level in the link under each purpose. Some vendors may process your data based on their legitimate interests, which does not require your consent. You cannot object to tracking technologies placed to ensure security, prevent fraud, fix errors, or deliver and present advertising and content, and precise geolocation data and active scanning of device characteristics for identification may be used to support this purpose. This exception does not apply to targeted advertising. These choices will be signaled to our vendors participating in the Transparency and Consent Framework.
Manage Consent Preferences
Necessary Cookies
Always Active
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work.
Targeting Cookies
These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.
Functional Cookies
These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then these services may not function properly.
Performance Cookies
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not be able to monitor our performance.
Store and/or access information on a device 109 partners can use this purpose
Cookies, device or similar online identifiers (e.g. login-based identifiers, randomly assigned identifiers, network based identifiers) together with other information (e.g. browser type and information, language, screen size, supported technologies etc.) can be stored or read on your device to recognise it each time it connects to an app or to a website, for one or several of the purposes presented here.
Personalised advertising and content, advertising and content measurement, audience research and services development 141 partners can use this purpose
Use limited data to select advertising 111 partners can use this purpose
Advertising presented to you on this service can be based on limited data, such as the website or app you are using, your non-precise location, your device type or which content you are (or have been) interacting with (for example, to limit the number of times an ad is presented to you).
Create profiles for personalised advertising 83 partners can use this purpose
Information about your activity on this service (such as forms you submit, content you look at) can be stored and combined with other information about you (for example, information from your previous activity on this service and other websites or apps) or similar users. This is then used to build or improve a profile about you (that might include possible interests and personal aspects). Your profile can be used (also later) to present advertising that appears more relevant based on your possible interests by this and other entities.
Use profiles to select personalised advertising 83 partners can use this purpose
Advertising presented to you on this service can be based on your advertising profiles, which can reflect your activity on this service or other websites or apps (like the forms you submit, content you look at), possible interests and personal aspects.
Create profiles to personalise content 38 partners can use this purpose
Information about your activity on this service (for instance, forms you submit, non-advertising content you look at) can be stored and combined with other information about you (such as your previous activity on this service or other websites or apps) or similar users. This is then used to build or improve a profile about you (which might for example include possible interests and personal aspects). Your profile can be used (also later) to present content that appears more relevant based on your possible interests, such as by adapting the order in which content is shown to you, so that it is even easier for you to find content that matches your interests.
Use profiles to select personalised content 34 partners can use this purpose
Content presented to you on this service can be based on your content personalisation profiles, which can reflect your activity on this or other services (for instance, the forms you submit, content you look at), possible interests and personal aspects. This can for example be used to adapt the order in which content is shown to you, so that it is even easier for you to find (non-advertising) content that matches your interests.
Measure advertising performance 132 partners can use this purpose
Information regarding which advertising is presented to you and how you interact with it can be used to determine how well an advert has worked for you or other users and whether the goals of the advertising were reached. For instance, whether you saw an ad, whether you clicked on it, whether it led you to buy a product or visit a website, etc. This is very helpful to understand the relevance of advertising campaigns.
Measure content performance 60 partners can use this purpose
Information regarding which content is presented to you and how you interact with it can be used to determine whether the (non-advertising) content e.g. reached its intended audience and matched your interests. For instance, whether you read an article, watch a video, listen to a podcast or look at a product description, how long you spent on this service and the web pages you visit etc. This is very helpful to understand the relevance of (non-advertising) content that is shown to you.
Understand audiences through statistics or combinations of data from different sources 74 partners can use this purpose
Reports can be generated based on the combination of data sets (like user profiles, statistics, market research, analytics data) regarding your interactions and those of other users with advertising or (non-advertising) content to identify common characteristics (for instance, to determine which target audiences are more receptive to an ad campaign or to certain contents).
Develop and improve services 83 partners can use this purpose
Information about your activity on this service, such as your interaction with ads or content, can be very helpful to improve products and services and to build new products and services based on user interactions, the type of audience, etc. This specific purpose does not include the development or improvement of user profiles and identifiers.
Use limited data to select content 38 partners can use this purpose
Content presented to you on this service can be based on limited data, such as the website or app you are using, your non-precise location, your device type, or which content you are (or have been) interacting with (for example, to limit the number of times a video or an article is presented to you).
Use precise geolocation data 46 partners can use this special feature
With your acceptance, your precise location (within a radius of less than 500 metres) may be used in support of the purposes explained in this notice.
Actively scan device characteristics for identification 27 partners can use this special feature
With your acceptance, certain characteristics specific to your device might be requested and used to distinguish it from other devices (such as the installed fonts or plugins, the resolution of your screen) in support of the purposes explained in this notice.
Ensure security, prevent and detect fraud, and fix errors 90 partners can use this special purpose
Always Active
Your data can be used to monitor for and prevent unusual and possibly fraudulent activity (for example, regarding advertising, ad clicks by bots), and ensure systems and processes work properly and securely. It can also be used to correct any problems you, the publisher or the advertiser may encounter in the delivery of content and ads and in your interaction with them.
Deliver and present advertising and content 97 partners can use this special purpose
Always Active
Certain information (like an IP address or device capabilities) is used to ensure the technical compatibility of the content or advertising, and to facilitate the transmission of the content or ad to your device.
Match and combine data from other data sources 72 partners can use this feature
Always Active
Information about your activity on this service may be matched and combined with other information relating to you and originating from various sources (for instance your activity on a separate online service, your use of a loyalty card in-store, or your answers to a survey), in support of the purposes explained in this notice.
Link different devices 53 partners can use this feature
Always Active
In support of the purposes explained in this notice, your device might be considered as likely linked to other devices that belong to you or your household (for instance because you are logged in to the same service on both your phone and your computer, or because you may use the same Internet connection on both devices).
Identify devices based on information transmitted automatically 86 partners can use this feature
Always Active
Your device might be distinguished from other devices based on information it automatically sends when accessing the Internet (for instance, the IP address of your Internet connection or the type of browser you are using) in support of the purposes exposed in this notice.
Save and communicate privacy choices 68 partners can use this special purpose
Always Active
The choices you make regarding the purposes and entities listed in this notice are saved and made available to those entities in the form of digital signals (such as a string of characters). This is necessary in order to enable both this service and those entities to respect such choices.
have your say